{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:29:31Z","timestamp":1768033771122,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Resident Translational Research Project Award"},{"name":"Department of Pathology at New York University Langone Health"},{"name":"Laura and Isaac Perlmutter Cancer Center Support","award":["NIH\/NCI P30CA016087"],"award-info":[{"award-number":["NIH\/NCI P30CA016087"]}]},{"name":"NIH S10","award":["NIH\/ORIP S10OD01058"],"award-info":[{"award-number":["NIH\/ORIP S10OD01058"]}]},{"name":"NIH S10","award":["S10OD018338"],"award-info":[{"award-number":["S10OD018338"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.prp.2020.153041","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:30:01Z","timestamp":1591097401000},"page":"153041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions"],"prefix":"10.1016","volume":"216","author":[{"given":"Theodore","family":"Vougiouklakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J.","family":"Belovarac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lytle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Chiriboga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Ozerdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.153041_bib0005","first-page":"813","article-title":"Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases","volume":"7","author":"Tavassoli","year":"1994","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2020.153041_bib0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/00000478-199909000-00007","article-title":"Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type\u2014benign and malignant intraductal proliferations","volume":"23","author":"Moinfar","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2020.153041_bib0015","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.5858\/133.11.1817","article-title":"Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case","volume":"133","author":"Visscher","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2020.153041_bib0020","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1798::AID-CNCR15>3.0.CO;2-0","article-title":"Consensus conference on the classification of ductal carcinoma in situ. The consensus conference committee","volume":"80","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2020.153041_bib0025","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.prp.2020.153041_bib0030","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-10-2156","article-title":"Aberrations of EZH2 in cancer","volume":"17","author":"Chase","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.153041_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Simon","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.prp.2020.153041_bib0040","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1078-0432.CCR-05-1533","article-title":"Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer","volume":"12","author":"Collett","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.153041_bib0045","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1158\/0008-5472.CAN-05-4300","article-title":"Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues","volume":"66","author":"Ding","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.153041_bib0050","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1158\/0008-5472.CAN-06-2384","article-title":"Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast","volume":"66","author":"Ding","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.153041_bib0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/modpathol.2011.8","article-title":"EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development","volume":"24","author":"Kunju","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2020.153041_bib0060","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.4161\/cc.25065","article-title":"EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer","volume":"12","author":"Knudsen","year":"2013","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/j.prp.2020.153041_bib0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00428-016-1966-1","article-title":"Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast","volume":"469","author":"Tramm","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2020.153041_bib0070","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2529::AID-CNCR16>3.0.CO;2-U","article-title":"Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up","volume":"77","author":"Seidman","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2020.153041_bib0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5858\/arpa.2011-0225-OA","article-title":"Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients","volume":"136","author":"Fuehrer","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2020.153041_bib0080","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.5858\/arpa.2016-0238-RA","article-title":"Atypical apocrine adenosis: diagnostic challenges and pitfalls","volume":"140","author":"Asirvatham","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2020.153041_bib0085","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.humpath.2014.06.010","article-title":"Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management","volume":"45","author":"Calhoun","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2020.153041_bib0090","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ncb3626","article-title":"EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation","volume":"19","author":"Rondinelli","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.prp.2020.153041_bib0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-013-2560-8","article-title":"Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry","volume":"139","author":"Inwald","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2020.153041_bib0100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/bjc.2013.147","article-title":"Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype","volume":"108","author":"Lazzeroni","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2020.153041_bib0105","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/modpathol.3800082","article-title":"Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases","volume":"17","author":"Bankfalvi","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2020.153041_bib0110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/path.1241","article-title":"Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ","volume":"198","author":"Boecker","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2020.153041_bib0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-2559.2000.00882.x","article-title":"Cytokeratin 5\/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast","volume":"37","author":"Otterbach","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2020.153041_bib0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e31820598a2","article-title":"Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast","volume":"35","author":"Tramm","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2020.153041_bib0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0344-0338(97)80053-2","article-title":"Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ","volume":"193","author":"Gatalica","year":"1997","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2020.153041_bib0130","first-page":"1","article-title":"Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients","volume":"4","author":"Carter","year":"1991","journal-title":"Mod. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820308761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820308761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:42:18Z","timestamp":1759732938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820308761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0344033820308761"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153041","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153041"}}